Log in
Enquire now
‌

US Patent 9701729 Peptide having 5 linked CTL epitopes

Patent 9701729 was granted and assigned to Taiho Pharmaceutical on July, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Taiho Pharmaceutical
Taiho Pharmaceutical
0
Current Assignee
Taiho Pharmaceutical
Taiho Pharmaceutical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
97017290
Patent Inventor Names
Toshihiro Osada0
Hiroshi Wada0
Satoshi Fukaya0
Teruhiro Utsugi0
Date of Patent
July 11, 2017
0
Patent Application Number
147731400
Date Filed
March 5, 2014
0
Patent Primary Examiner
‌
Sheela J. Huff
0
Patent abstract

This invention provides a cancer antigen peptide that can be administered to a wide range of cancer patients in the form of a peptide vaccine for cancer without the need for HLA typing and regardless of the HLA types of patients. Such peptide having 5 linked CTL epitopes is obtained by linking 5 CTL epitope peptides selected from among CTL epitope peptides derived from tumor antigen molecules that are reported to have the capacity for CTL induction via linkers.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9701729 Peptide having 5 linked CTL epitopes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.